ARCHIVES

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

ASCO Urges Doubling Cooperative Group Program Budget

April 16, 2010

In Brief: Wells Tapped For GM Cancer Foundation; Calder Named NABCO Associate Director

January 17, 1997

United Approach With Other Health Advocates Needed To Increase Cancer Dollars, Royboal Says

February 10, 1978

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

Studies Link Age-Dependent Outcome To Immune Cells

November 28, 2003